{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:22:34Z","timestamp":1784290954837,"version":"3.55.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejim.2025.106562","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T20:26:10Z","timestamp":1761769570000},"page":"106562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multimodality imaging for cardiac amyloidosis: clinical applications and future directions"],"prefix":"10.1016","volume":"144","author":[{"given":"G","family":"Sinigiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cecchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-6202","authenticated-orcid":false,"given":"A","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10038","key":"10.1016\/j.ejim.2025.106562_bib0001","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejim.2025.106562_bib0002","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1161\/CIRCULATIONAHA.111.069195","article-title":"Cardiac amyloidosis","volume":"126","author":"Quarta","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trend Cardiovasc Med"},{"issue":"13","key":"10.1016\/j.ejim.2025.106562_bib0004","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0006","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ejim.2025.106562_bib0007","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ejim.2025.106562_bib0008","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101232","article-title":"Impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis","volume":"3","author":"Tini","year":"2024","journal-title":"JACC Adv"},{"issue":"11","key":"10.1016\/j.ejim.2025.106562_bib0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin Amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106562_bib0011","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","author":"Fontana","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0013","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.3390\/jcm14103481","article-title":"Pharmacological management of Transthyretin amyloid cardiomyopathy: where we are and where we are going","volume":"14","author":"De Michieli","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-imaging characterization of cardiac phenotype in different types of amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0016","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","article-title":"Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value","volume":"4","author":"Cipriani","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0017","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10554-023-02901-2","article-title":"Valve disease in cardiac amyloidosis: an echocardiographic score","volume":"39","author":"Aimo","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"issue":"13","key":"10.1016\/j.ejim.2025.106562_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034723","article-title":"Prevalence, characteristics, and impact on prognosis of aortic stenosis in patients with cardiac amyloidosis","volume":"13","author":"Annabi","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.ejim.2025.106562_bib0019","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0022","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.ejim.2025.106562_bib0024","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1093\/ehjci\/jeae111","article-title":"Atrial electromechanical dissociation in cardiac amyloidosis","volume":"25","author":"Zhao","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.ejim.2025.106562_bib0025","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.ejim.2025.106562_bib0026","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/ehjci\/jead107","article-title":"Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient","volume":"24","author":"De Gaspari","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0027","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ehjci\/jead032","article-title":"Prevalence and significance of relative apical sparing in aortic stenosis: insights from an echo and cardiovascular magnetic resonance study of patients referred for surgical aortic valve replacement","volume":"24","author":"Abecasis","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0028","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2025.106562_bib0029","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13506129.2016.1194264","article-title":"Prognostic value of right ventricular systolic function in cardiac amyloidosis","volume":"23","author":"Bodez","year":"2016","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.echo.2024.06.006","article-title":"Right ventricular strain improves the echocardiographic diagnosis and risk stratification of transthyretin cardiac amyloidosis among other phenotypes of left ventricular hypertrophy","volume":"37","author":"Ozbay","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2025.106562_bib0031","first-page":"jeae242","article-title":"Right ventricular free wall strain predicts ATTR prognosis as well as biomarker- based staging systems","author":"Istratoaie","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ejim.2025.106562_bib0032","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.echo.2024.08.013","article-title":"Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis","volume":"37","author":"Meucci","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0033","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10554-025-03394-x","article-title":"Right ventricular to pulmonary artery uncoupling is an early predictor of poor outcome in wild-type transthyretin amyloid cardiomyopathy","volume":"41","author":"Sinigiani","year":"2025","journal-title":"Int J Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2025.106562_bib0034","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jcmg.2023.01.015","article-title":"Prognostic utility of left atrial strain to predict thrombotic events and mortality in amyloid cardiomyopathy","volume":"16","author":"Akintoye","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0035","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jacep.2023.03.013","article-title":"Left atrial strain may predict thrombus formation in patients with transthyretin cardiac amyloidosis","volume":"9","author":"Donnellan","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0036","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.ejim.2025.106562_bib0037","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ejhf.2606","article-title":"Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis","volume":"24","author":"Chacko","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0038","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006588","article-title":"Independent prognostic value of stroke volume index in patients with immunoglobulin light chain amyloidosis","volume":"11","author":"Milani","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0041","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ejechocard\/jer289","article-title":"Right ventricular function in AL amyloidosis: characteristics and prognostic implication","volume":"13","author":"Cappelli","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0042","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","article-title":"Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis","volume":"9","author":"Ghio","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.106562_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.05.058","article-title":"Association between the TAPSE to PASP ratio and short-term outcome in patients with light-chain cardiac amyloidosis","volume":"387","author":"Yu","year":"2023","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0044","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ehjci\/jead145","article-title":"Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis","volume":"24","author":"Tomasoni","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaccao.2020.10.010","article-title":"Left atrial mechanics associates with paroxysmal atrial fibrillation in light-chain amyloidosis following stem cell transplantation","volume":"2","author":"Lohrmann","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.ejim.2025.106562_bib0046","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/echo.15516","article-title":"Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis","volume":"40","author":"Cotella","year":"2023","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0047","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms","volume":"12","author":"Goto","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101755","article-title":"Echocardiographic tissue characterization using radiomics in patients with transthyretin-related cardiac amyloidosis","volume":"4","author":"Mori","year":"2025","journal-title":"JACC Adv"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0049","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: A practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.ejim.2025.106562_bib0051","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ejim.2025.106562_bib0052","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2025.106562_bib0053","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcmg.2012.04.006","article-title":"Quantification of extracellular matrix expansion by CMR in infiltrative heart disease","volume":"5","author":"Mongeon","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0054","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ejim.2025.106562_bib0055","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0056","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2025.106562_bib0057","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCULATIONAHA.124.072460","article-title":"AL or ATTR amyloidosis? Never two without three","volume":"151","author":"Nuvolone","year":"2025","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0058","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by Cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2025.106562_bib0059","article-title":"Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: prognostic and clinical correlates","volume":"31","author":"Aquaro","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hrthm.2024.01.056","article-title":"Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis","volume":"21","author":"Sinigiani","year":"2024","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0061","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2025.106562_bib0062","first-page":"ehaf412","article-title":"Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance","author":"Patel","year":"2025","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ejim.2025.106562_bib0063","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMc2304584","article-title":"Antibody-associated reversal of ATTR amyloidosis-related cardiomyopathy","volume":"388","author":"Fontana","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0064","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0065","first-page":"319","article-title":"Cardiac Magnetic resonance-detected acute myocardial edema as predictor of favourable prognosis: a comprehensive review","volume":"10","author":"Sinigiani","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"9","key":"10.1016\/j.ejim.2025.106562_bib0066","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping","volume":"8","author":"Ioannou","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"45","key":"10.1016\/j.ejim.2025.106562_bib0067","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2025.106562_bib0068","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamacardio.2024.2555","article-title":"Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis","volume":"9","author":"Porcari","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0069","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jchf.2024.07.003","article-title":"The pathophysiological and therapeutic implications of cardiac light-chain amyloidosis compared with transthyretin amyloidosis","volume":"12","author":"Schilling","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101051","article-title":"Improving the efficiency and accuracy of cardiovascular magnetic resonance with artificial intelligence-review of evidence and proposition of a roadmap to clinical translation","volume":"26","author":"Zhang","year":"2024","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0071","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0072","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.ejim.2025.106562_bib0073","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/eurjpc\/zwac237","article-title":"Comparison of different technetium-99m-labelled bone tracers for imaging cardiac amyloidosis","volume":"30","author":"Porcari","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2025.106562_bib0074","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in Cardiac amyloidosis:part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0076","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0077","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0078","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2025.106562_bib0079","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-Evuzamitide (124I-P5+14) versus 18F-florbetapir: A pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2025.106562_bib0080","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of Iodine (124I) evuzamitide (124I-p5+14): A phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2025.106562_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112188","article-title":"Head-to-head comparison of [18F]florbetapir and [18F]FDG PET for the early detection of amyloidosis in systemic amyloidosis and plasma cell dyscrasias","volume":"189","author":"Kong","year":"2025","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0082","first-page":"184","article-title":"Semi-quantification of myocardial uptake of bone-seeking agents in suspected cardiac amyloidosis","volume":"10","author":"Campi","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"17","key":"10.1016\/j.ejim.2025.106562_bib0083","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.3390\/jcm12175698","article-title":"Prevalence of incidental findings suspicious for transthyretin cardiac amyloidosis among patients undergoing bone scintigraphy: A systematic review and a meta-analysis","volume":"12","author":"Treglia","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0084","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ejhf.2823","article-title":"Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study","volume":"25","author":"Tini","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.5221","article-title":"Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration","volume":"10","author":"Porcari","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2025.106562_bib0086","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2017.10.027","article-title":"Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: an underestimated phenomenon","volume":"254","author":"Cappelli","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106562_bib0087","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-022-01995-x","article-title":"Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients","volume":"23","author":"Monfort","year":"2022","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.ejim.2025.106562_bib0088","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jamacardio.2024.0022","article-title":"Cardiopulmonary exercise testing in evaluating transthyretin amyloidosis","volume":"9","author":"Patel","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2025.106562_bib0089","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of Planar Technetium 99m pyrophosphate cardiac Imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101261","article-title":"DPD quantification correlates with extracellular volume and disease severity in wild-type transthyretin cardiac amyloidosis","volume":"3","author":"Rettl","year":"2024","journal-title":"JACC Adv"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0092","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1007\/s12350-022-02961-2","article-title":"Incidental cardiac uptake of 99mTc-diphosphonates is predictive of poor outcome: data from 9616 bone scintigraphies","volume":"29","author":"Salvalaggio","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"15","key":"10.1016\/j.ejim.2025.106562_bib0093","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.123.066524","article-title":"Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy","volume":"149","author":"Porcari","year":"2024","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ejim.2025.106562_bib0094","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2967\/jnumed.122.265352","article-title":"Regression of myocardial 99mTc-DPD uptake after Tafamidis treatment of cardiac transthyretin amyloidosis","volume":"64","author":"Papathanasiou","year":"2023","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","article-title":"Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy","volume":"24","author":"Rettl","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2025.106562_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2025.03.014","article-title":"Uncertain clinical relevance of serial bone scintigraphy findings in treated transthyretin amyloid cardiomyopathy","author":"Razvi","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ejim.2025.106562_bib0097","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2967\/jnumed.121.263033","article-title":"Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis","volume":"63","author":"Choi","year":"2022","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.106562_bib0098","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular 18F-florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0099","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ehjci\/jead350","article-title":"Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography\/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis","volume":"25","author":"Datar","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2025.106562_bib0100","first-page":"jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben PET predicts all-cause mortality in light-chain cardiac amyloidosis","author":"Vergaro","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ejim.2025.106562_bib0101","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00259-025-07117-1","article-title":"Artificial intelligence-based cardiac transthyretin amyloidosis detection and scoring in scintigraphy imaging: multi-tracer, multi-scanner, and multi-center development and evaluation study","volume":"52","author":"Salimi","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.ejim.2025.106562_bib0102","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s12350-023-03214-6","article-title":"Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: how to reduce equivocal and false positive studies","volume":"30","author":"Al Taha","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0103","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00330-017-4984-8","article-title":"Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study","volume":"28","author":"Chevance","year":"2018","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0104","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","article-title":"Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis","volume":"9","author":"Treibel","year":"2015","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"10.1016\/j.ejim.2025.106562_bib0105","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jcmg.2020.05.029","article-title":"Identifying cardiac amyloid in aortic stenosis: ECV quantification by CT in TAVR patients","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ejim.2025.106562_bib0106","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jcmg.2022.08.006","article-title":"Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis","volume":"15","author":"Gama","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ejim.2025.106562_bib0107","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2021204192","article-title":"Diagnostic value of extracellular volume quantification and myocardial perfusion analysis at CT in cardiac amyloidosis","volume":"300","author":"Deux","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2025.106562_bib0108","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000001198","article-title":"Evaluation of extracellular volume and coronary artery disease in cardiac amyloidosis using photon-counting CT","author":"Popp","year":"2025","journal-title":"Invest Radiol"},{"key":"10.1016\/j.ejim.2025.106562_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131204","article-title":"Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance","volume":"389","author":"De Michieli","year":"2023","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106562_bib0110","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ehjci\/jeaf071","article-title":"Development and validation of a radiomics model for detecting cardiac amyloidosis at coronary computed tomography angiography","volume":"26","author":"Meng","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:21:43Z","timestamp":1781911303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052500439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":110,"alternative-id":["S095362052500439X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106562","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality imaging for cardiac amyloidosis: clinical applications and future directions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106562"}}